menu
    • menu

    Company profile for Cyrano Therapeutics

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A financing led by Remiges Ventures and Lumira Ventures, with the participation of additional investors. The funds will be used to complete a Phase 2 clinical trial of the company’s lead product, CYR-064, in the U.S. and Europe. As part of the financ...
    Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A financing led by Remiges Ventures and Lumira Ventures, with the participation of additional investors. The funds will be used to complete a Phase 2 clinical trial of the company’s lead product, CYR-064, in the U.S. and Europe. As part of the financing, Taka Koda of Remiges Ventures and Gerry Brunk of Lumira Ventures have joined the company’s board of directors. Currently no FDA-approved therapy for this serious condition afflicting over 15 million.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cyrano TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    MacArthur Blvd. NW, #20 Washington, DC 20016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cyranotherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cyrano-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cyrano Therapeutics Announces Positive Phase 2 CYR-064 Results
    Cyrano Therapeutics Announces Positive Phase 2 CYR-064 Results

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cyrano-therapeutics-announces-positive-topline-results-from-phase-2-flavor-trial-of-cyr-064-a-proprietary-and-potential-first-to-market-regenerative-therapy-for-persistent-smell-loss-302689451.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Cyrano Therapeutics Completes Enrollment in Phase 2 Flavor Trial
    Cyrano Therapeutics Completes Enrollment in Phase 2 Flavor Trial

    10 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cyrano-therapeutics-completes-enrollment-in-phase-2-flavor-trial-of-cyr-064-for-post-viral-smell-loss-302425007.html

    PR NEWSWIRE
    10 Apr 2025
    Share Share
    Kyorin & Cyrano Therapeutics Option Agreement for CYR-064 in Japan
    Kyorin & Cyrano Therapeutics Option Agreement for CYR-064 in Japan

    18 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kyorin-and-cyrano-therapeutics-enter-into-an-option-agreement-for-cyr-064-for-the-treatment-of-post-viral-loss-of-smell-in-japan-302378067.html

    PR NEWSWIRE
    18 Feb 2025
    Share Share
    Cyrano Launch Study on CYR-064 for Hyposmia in Parkinson’s Disease
    Cyrano Launch Study on CYR-064 for Hyposmia in Parkinson’s Disease

    04 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cyrano-therapeutics-announces-the-launch-of-an-investigator-initiated-clinical-study-evaluating-cyr-064-for-the-loss-of-smell-hyposmia-in-parkinsons-disease-patients-302367016.html

    PR NEWSWIRE
    04 Feb 2025
    Share Share
    Cyrano Therapeutics Secures $9.0 Million Series B Financing
    Cyrano Therapeutics Secures $9.0 Million Series B Financing

    16 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cyrano-therapeutics-secures-9-0-million-series-b-financing-to-advance-clinical-development-of-cyr-064-for-treatment-of-post-viral-smell-loss-302031744.html

    PR NEWSWIRE
    16 Jan 2024
    Share Share
    Cyrano Therapeutics Enrolls First Patient in Phase 2 Trial of CYR-064
    Cyrano Therapeutics Enrolls First Patient in Phase 2 Trial of CYR-064

    12 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cyrano-therapeutics-enrolls-first-patient-in-phase-2-trial-of-cyr-064-for-post-viral-smell-loss-hyposmia-301954527.html

    PR NEWSWIRE
    12 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search